Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil Vaccine to Prevent HPV Infection

NCT00524745 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT00524745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00524745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil Vaccine to Prevent HPV Infection
Lead sponsor
PATH
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2007
Completion date
January 31, 2010
Enrollment
903 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dose schedule study